arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Celldex Therapeutics, Inc.

CLDX Health Care Biotechnology: In Vitro & In Vivo Diagnostic Substances
$28.97
▼ -4.4% Today
as of Oct 22, 16:47 ET
Last 30 days -26.06% Sep 14 → Oct 22
$26.60 $29.98 $33.36 $36.73 $40.11 Sep 14 Sep 22 Sep 29 Oct 07 Oct 14 Oct 22
Open
$29.05
High
$29.73
Low
$28.49
Volume
$877,930
Avg Vol
$1M
Mkt Cap
$2.5B
P/E (TTM)
—
Beta
—
52w High
$45.14
52w Low
$22.10
Div Yield
—
Shares Out
$79M

Recent Press Releases & News last 60 days · 9 items

Oct 17 · 00:15 Simply Wall St.
Celldex Therapeutics (CLDX) Stock Looks Rich After Shareholder Investigation
Sep 23 · 12:41 Insider Monkey
Can Celldex (CLDX) Overcome Its Heavy Burn Rate for Long-Term Success?
Sep 23 · 12:37 Zacks
The Zacks Analyst Blog Highlights Kodiak Sciences, Celldex Therapeutics, Rapport Therapeutics and Vaxcyte
▸ Show all 9 press releases & news Free account →

CLDX earnings at a glance

The options market is pricing a move of about ±4.5% after the report, a range of roughly $27.66 to $30.28 from today's $28.97. Over its last 2 reports the stock rose the next day 1 time and fell 1, moving ±3.2% on average; after the most recent report on May 7, 2026 it moved -3.1%. That means options currently expect more movement than CLDX has typically delivered. CLDX beat the consensus EPS estimate in 1 of its last 4 reported quarters. Implied volatility is currently 38%. The share price of $28.97 sits in the middle of its 52-week range.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$22
$45
30% of range
Avg surprise (last 4)
-7.2%
Avg reaction (last 2)
+0.1%
50% positive
Latest IV / EM
38%
EM ±4.5% · $29 · Oct 16

Earnings trends

EPS — actual vs estimate Actual Estimate
$-1.18$-1.02$-0.86$-0.70$-0.54 Actual $-0.62Actual $-0.65Actual $-0.81Actual $-0.56Actual $-0.54Actual $-0.64Actual $-0.81Est $-0.75Actual $-0.85Est $-0.86Actual $-1.01Est $-0.88Actual $-1.18Est $-1.10Actual $-0.94 MarJunSepMarJunSepMar/2025Jun/2025Sep/2025Mar/2026Jun
Revenue vs Net Income Revenue Net income
$-79M$-58M$-38M$-17M$3M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $-0.94 — — — — financials
Thu May 7, 2026Mar/2026 $-1.18 $-1.10 -7.3% -45.7% -3.1% earnings
Mon Nov 10, 2025Sep/2025 $-1.01 $-0.88 -14.8% — — earnings
Thu Aug 7, 2025Jun/2025 $-0.85 $-0.86 +1.2% — — earnings
Thu May 8, 2025Mar/2025 $-0.81 $-0.75 -8.0% — +3.2% earnings
Mon Sep 30, 2024Sep 2024 $-0.64 — — — — financials
Sun Jun 30, 2024Jun 2024 $-0.54 — — — — financials
Sun Mar 31, 2024Mar 2024 $-0.56 — — — — financials
Sat Sep 30, 2023Sep 2023 $-0.81 — — — — financials
Fri Jun 30, 2023Jun 2023 $-0.65 — — — — financials
Fri Mar 31, 2023Mar 2023 $-0.62 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$22,000$15,000——$730,000$695,000—$3M
Cost of revenue————————
Gross profit————————
Operating income$-81M$-84M—$-74M$-64M$-63M—$-52M
Net income$-74M$-79M—$-67M$-57M$-54M—$-42M
EPS (diluted)$-0.94$-1.18—$-1.01$-0.85$-0.81—$-0.64

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$47M$36M$29M$36M$23M$17M$28M$36M
Inventory————————
Total current assets$725M$459M$535M$604M$648M$694M$747M$779M
Total assets$782M$511M$583M$648M$692M$739M$792M$823M
Long-term debt————————
Total liabilities$68M$55M$56M$50M$37M$36M$45M$37M
Total equity$715M$456M$527M$598M$655M$703M$747M$786M

Implied volatility — last 90 days

35%100%165%231%296% Jun 07 — IV 112% · EM ±15.5%Jun 09 — IV 121% · EM ±15.1%Jun 11 — IV 59% · EM ±6.5%Jun 12 — IV 56% · EM ±5.8%Jun 15 — IV 54% · EM ±3.9%Jun 16 — IV 134% · EM ±7.9%Jun 17 — IV 242% · EM ±10.1%Jun 19 — IV 63% · EM ±14.0%Jun 22 — IV 45% · EM ±9.4%Jun 23 — IV 57% · EM ±11.6%Jun 24 — IV 58% · EM ±11.6%Jun 25 — IV 67% · EM ±13.1%Jun 26 — IV 65% · EM ±12.5%Jun 29 — IV 59% · EM ±10.5%Jun 30 — IV 50% · EM ±8.6%Jul 01 — IV 50% · EM ±8.4%Jul 02 — IV 86% · EM ±13.9%Jul 03 — IV 89% · EM ±13.9%Jul 06 — IV 58% · EM ±8.0%Jul 07 — IV 74% · EM ±9.8%Jul 08 — IV 71% · EM ±8.9%Jul 09 — IV 97% · EM ±11.4%Jul 13 — IV 95% · EM ±7.9%Jul 15 — IV 220% · EM ±13.0%Jul 16 — IV 101% · EM ±4.2%Jul 20 — IV 54% · EM ±12.7%Jul 21 — IV 112% · EM ±26.1%Jul 22 — IV 53% · EM ±12.0%Jul 23 — IV 62% · EM ±14.0%Jul 24 — IV 48% · EM ±10.6%Jul 27 — IV 73% · EM ±15.3%Jul 29 — IV 39% · EM ±7.9%Jul 30 — IV 42% · EM ±8.3%Jul 31 — IV 53% · EM ±10.1%Aug 04 — IV 43% · EM ±7.4%Aug 05 — IV 90% · EM ±15.1%Aug 10 — IV 71% · EM ±9.8%Aug 11 — IV 54% · EM ±7.1%Aug 12 — IV 70% · EM ±8.7%Aug 13 — IV 46% · EM ±5.4%Aug 14 — IV 70% · EM ±7.7%Aug 17 — IV 99% · EM ±8.2%Aug 18 — IV 101% · EM ±7.3%Aug 19 — IV 122% · EM ±7.2%Aug 20 — IV 297% · EM ±12.4%Aug 24 — IV 70% · EM ±14.7%Aug 25 — IV 64% · EM ±13.0%Aug 26 — IV 83% · EM ±16.6%Aug 27 — IV 64% · EM ±12.5%Aug 28 — IV 75% · EM ±14.3%Aug 31 — IV 69% · EM ±12.3%Sep 01 — IV 78% · EM ±13.4%Sep 02 — IV 80% · EM ±13.4%Sep 03 — IV 88% · EM ±14.2%Sep 04 — IV 110% · EM ±17.2%Sep 07 — IV 124% · EM ±17.2%Sep 08 — IV 100% · EM ±13.2%Sep 09 — IV 117% · EM ±14.7%Sep 10 — IV 111% · EM ±13.1%Sep 11 — IV 132% · EM ±14.6%Sep 14 — IV 170% · EM ±14.2%Sep 15 — IV 154% · EM ±11.2%Sep 16 — IV 217% · EM ±12.8%Sep 17 — IV 250% · EM ±10.5%Sep 21 — IV 208% · EM ±43.4%Sep 22 — IV 82% · EM ±16.8%Sep 23 — IV 69% · EM ±13.7%Sep 24 — IV 39% · EM ±7.5%Sep 25 — IV 50% · EM ±9.6%Sep 28 — IV 42% · EM ±7.5%Sep 29 — IV 39% · EM ±6.8%Sep 30 — IV 35% · EM ±5.9%Oct 01 — IV 48% · EM ±7.7%Oct 02 — IV 36% · EM ±5.6%Oct 06 — IV 35% · EM ±4.7%Oct 07 — IV 49% · EM ±6.2%Oct 08 — IV 38% · EM ±4.5%

Sector peers

NTLA
Intellia Therapeutics, Inc.
$1.6B $11.16-5.7%
QDEL
QuidelOrtho Corporation
$844M $13.48-5.1%
ACHV
Achieve Life Sciences, Inc.
$745M $6.50-0.1%
TKNO
Alpha Teknova, Inc.
$468M $6.15-16.8%
MYGN
Myriad Genetics, Inc.
$409M $5.76+4.0%
IMDX
Insight Molecular Diagnostics Inc.
$114M $2.84-6.3%

CLDX earnings FAQ

What is CLDX's expected move for earnings?

Options currently price a move of about ±4.5%, or $1.31 per share either way from $28.97.

How does CLDX stock usually react to earnings?

Across the last 2 reports the average next-day move was ±3.2%, up 1 times and down 1 times.

What is CLDX's implied volatility?

CLDX's at-the-money implied volatility is about 38% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in